There’s no single “best” peptide for bodybuilding because it depends on your goal. If you want to build muscle, a growth hormone secretagogue like CJC-1295 paired with Ipamorelin is the most popular choice. If you’re dealing with nagging injuries, BPC-157 and TB-500 are widely used for recovery. And if cutting fat while preserving muscle is the priority, tesamorelin and AOD9604 target fat metabolism specifically. Here’s how each one works and what to realistically expect.
For Muscle Growth: CJC-1295 and Ipamorelin
The combination of CJC-1295 and Ipamorelin is the most commonly recommended peptide stack for building lean muscle. These two peptides work through different but complementary pathways. CJC-1295 is a growth hormone releasing hormone analog that extends the duration of each growth hormone pulse your body produces. Ipamorelin mimics ghrelin to trigger additional growth hormone release from the pituitary gland. Together, they amplify both the frequency and duration of your natural growth hormone output.
The downstream effect is what matters for muscle. Higher growth hormone levels stimulate your liver to produce more IGF-1, the primary driver of growth hormone’s anabolic effects. Elevated IGF-1 increases protein synthesis and nitrogen retention, both essential for building and preserving muscle tissue. Unlike injecting exogenous growth hormone directly, which often creates persistent, unnaturally high GH levels in the blood, secretagogues like these stimulate your body’s own pulsatile release pattern. That’s a meaningful distinction because pulsatile secretion is how GH naturally works, and it tends to produce fewer side effects than flatline elevated levels.
Typical protocols run 8 to 12 weeks. CJC-1295 without DAC (a long-acting modifier) is generally dosed at 100 to 200 mcg daily, often injected before bed to align with your body’s natural nighttime growth hormone spike. Ipamorelin is typically dosed at 200 to 300 mcg per day, split between morning and evening. Many users combine both injections at bedtime for simplicity.
For Recovery: BPC-157 and TB-500
Bodybuilders dealing with tendon pain, joint inflammation, or muscle tears frequently turn to BPC-157 and TB-500, sometimes called the “Wolverine stack.” These peptides don’t directly build muscle, but they can keep you training consistently, which is arguably more important than any single anabolic compound.
BPC-157 is a synthetic fragment of a protein found naturally in gastric juice. In animal studies, it accelerates healing of muscles, tendons, and ligaments while reducing inflammation. The proposed mechanisms include promoting new blood vessel growth, increasing nitric oxide production, and stimulating collagen formation. TB-500 (a synthetic version of thymosin beta-4) works differently, primarily by promoting cell migration to injury sites and reducing scar tissue formation.
Anecdotal timelines from users generally follow a pattern: reduced pain and inflammation within 1 to 2 weeks, improved mobility by weeks 2 to 4, and noticeable tissue regeneration by weeks 4 to 8. BPC-157 is typically dosed at 200 to 500 mcg per day, often split into two injections. TB-500 uses a loading protocol of 2 to 5 mg twice per week for 4 to 6 weeks, then drops to 2 mg once per week for maintenance.
One important caveat: human clinical data on both peptides is extremely limited. The FDA placed BPC-157 on its Category 2 list in September 2023, citing concerns about potential immune reactions and insufficient safety data for proposed routes of administration. Most of the evidence supporting these peptides comes from animal models and user reports, not controlled human trials.
For Fat Loss: Tesamorelin and AOD9604
If your goal is getting leaner while maintaining muscle, tesamorelin has the strongest clinical backing of any peptide in this category. It’s a synthetic growth hormone releasing hormone analog that the FDA approved for reducing abdominal fat in HIV patients with lipodystrophy. In two Phase III clinical trials, tesamorelin reduced visceral abdominal fat by 15% over 26 weeks without altering subcutaneous fat or overall BMI. Nearly 70% of subjects on tesamorelin achieved a clinically significant fat reduction of 8% or more, compared to 33% on placebo.
AOD9604 takes a different approach. It’s a modified fragment of the growth hormone molecule that isolates the fat-burning portion without the growth-promoting effects. In obese mice, 14 days of treatment reduced body weight and body fat while increasing sensitivity to fat breakdown. The appeal for bodybuilders is that AOD9604 appears to affect fat metabolism without raising blood sugar levels, a common concern with full growth hormone therapy. However, human data on AOD9604 remains thin compared to tesamorelin.
For Bulking: MK-677 (Ibutamoren)
MK-677 isn’t technically a peptide. It’s an oral compound that mimics ghrelin, the hunger hormone, and it’s popular during bulking phases for two reasons: it boosts growth hormone secretion and it significantly increases appetite. In a controlled trial of older adults, 67% of subjects taking MK-677 reported increased appetite compared to 36% on placebo. For about half of those users, the appetite spike returned to normal within three months, while others experienced a more gradual decline.
MK-677 boosted pulsatile growth hormone release by 1.7-fold over 24 hours in clinical studies. The oral dosing (no injections) makes it the most convenient option for sustained GH elevation.
The tradeoff is metabolic. MK-677 raised fasting blood glucose by an average of 5 mg/dL in clinical trials and increased HbA1c (a marker of long-term blood sugar control) by 0.2%. Insulin sensitivity also declined over 12 months of use. These are statistically significant but relatively small changes in healthy individuals. For anyone with prediabetes, insulin resistance, or a family history of type 2 diabetes, this is a real concern worth monitoring.
Competitive Athletes and WADA Rules
If you compete in any sport governed by the World Anti-Doping Agency, virtually every peptide used in bodybuilding is prohibited. The 2025 WADA Prohibited List bans all of the following under category S2: growth hormone and its analogs and fragments (covering AOD9604, HGH fragment 176-191), growth hormone releasing factors, secretagogues and mimetics (covering CJC-1295, Ipamorelin, GHRP-6, MK-677), and growth factors and growth factor modulators (covering IGF-1, TB-500). There is no gray area here for tested athletes.
Storage and Handling Basics
Most injectable peptides ship as freeze-dried powders that are stable at room temperature until you mix them. Once reconstituted with bacteriostatic water, they need to be refrigerated between 2 and 8°C (standard refrigerator temperature) and used within 28 days. Label each vial with the date you mixed it and the concentration. Letting reconstituted peptides sit at room temperature or using them past the 28-day window degrades potency and increases the risk of bacterial contamination.
Choosing Based on Your Goal
The “best” peptide depends entirely on what’s limiting your progress right now. If you’re training hard but not recovering well enough to maintain volume, BPC-157 and TB-500 address the bottleneck directly. If you’re eating in a surplus and want to maximize the anabolic environment, CJC-1295 with Ipamorelin gives you elevated growth hormone without injecting GH itself. If you’re in a cutting phase and struggling to lose stubborn abdominal fat, tesamorelin has the most clinical evidence behind it. And if you simply can’t eat enough to grow, MK-677’s appetite stimulation solves a practical problem that no amount of training programming can fix.
Keep in mind that none of these peptides are approved for bodybuilding purposes. Tesamorelin is the only one with full FDA approval, and that’s specifically for HIV-related abdominal fat accumulation. Everything else exists in a regulatory gray zone where the evidence is a mix of animal studies, off-label clinical data, and user experience. That doesn’t mean they don’t work, but it does mean you’re accepting a level of uncertainty about long-term safety that simply hasn’t been studied yet.